Clinical Trial: Obeservational Cohort for Evaluating Future Cardiovascular Disease With High Metabolic Risks

U.S., April 26 -- ClinicalTrials.gov registry received information related to the study (NCT06385431) titled 'Obeservational Cohort for Evaluating Future Cardiovascular Disease With High Metabolic Risks' on April 9.

Brief Summary: Cardiovascular and metabolic diseases refer to a large category of cardiovascular diseases accompanied by a series of metabolic disorders (including dyslipidemia, obesity, abnormal glucose tolerance, diabetes, hypertension, thyroid dysfunction, etc.), which is the primary cause of death and disease burden of Chinese residents.The number of deaths from atherosclerotic cardiovascular disease (ASCVD) in China is about 2.4 million, accounting for 61% of the total cardiovascular deaths, accounting for more than 40% of...